|
Anticoagulants
Citations 161-170 of 258 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke
- Valérie Wolff, Boris Aleil, Maurice Giroud, Jean-Louis Lorenzini, Nicolas Meyer, Marie-Louise Wiesel, Jean-Pierre Cazenave, and François Lanza
Stroke published February 3, 2005, doi:10.1161/01.STR.0000155738.02753.4d
[Abstract]
- Comments, Opinions, and Reviews
Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?
- Paul S.J. Miller, Fredrik L. Andersson, and Lalit Kalra
Stroke 2005;36:360-366; published online before print as doi:10.1161/01.STR.0000153002.56324.8c
[Abstract]
[Full text]
- Articles
Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?
- Paul S.J. Miller, Fredrik L. Andersson, and Lalit Kalra
Stroke published January 6, 2005, doi:10.1161/01.STR.0000153002.56324.8c
[Abstract]
- Cochrane Corner
Anticoagulants for Acute Ischemic Stroke
- Peter Sandercock, Gord Gubitz, and Carl Counsell
Stroke 2004;35:2916-2917; published online before print as doi:10.1161/01.STR.0000147725.45220.79
[Full text]
- Articles
Anticoagulants for Acute Ischemic Stroke
- Peter Sandercock, Gord Gubitz, and Carl Counsell
Stroke published November 4, 2004, doi:10.1161/01.STR.0000147725.45220.79
[Abstract]
- Original Contributions
Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
- Theresa I. Shireman, Patricia A. Howard, Timothy F. Kresowik, and Edward F. Ellerbeck
Stroke 2004;35:2362-2367; published online before print as doi:10.1161/01.STR.0000141933.75462.c2
[Abstract]
[Full text]
- Original Contributions
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients With Patent Foramen Ovale
- Shunichi Homma, Marco R. DiTullio, Ralph L. Sacco, Robert R. Sciacca, J.P. Mohr for PICSS Investigators
Stroke 2004;35:2145-2149; published online before print as doi:10.1161/01.STR.0000135773.24116.18
[Abstract]
[Full text]
- Articles
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients With Patent Foramen Ovale
- Shunichi Homma, Marco R. DiTullio, Ralph L. Sacco, Robert R. Sciacca, J. P. Mohr for PICSS Investigators
Stroke published July 1, 2004, doi:10.1161/01.STR.0000135773.24116.18
[Abstract]
- Letters to the Editor
Holter Monitoring Is Useful • Response
- Nicolas U. Weir, Michael D. Hill, B.A. Schaer, and Stefan Osswald
Stroke 2004;35:e336-337e, doi:10.1161/01.STR.0000131550.48926.f3
[Full text]
- Original Contributions
Argatroban Anticoagulation in Patients With Acute Ischemic Stroke (ARGIS-1): A Randomized, Placebo-Controlled Safety Study
- Marian P. LaMonte, Marshall L. Nash, David Z. Wang, Andrew R. Woolfenden, John Schultz, Marcie J. Hursting, Philip M. Brown for the ARGIS-1 Investigators
Stroke 2004;35:1677-1682; published online before print as doi:10.1161/01.STR.0000131549.20581.ba
[Abstract]
[Full text]
|
|
